Software & SaaS

CEO Adrian Mendes' major buy-in signals deep confidence as Perimeter Medical AI navigates FDA approval for its game-changing cancer surgery technology.

A prestigious Yale recognition for board member Dr. Curtis Patton bolsters Tevogen's credibility as it advances its AI and T-cell platforms.

As AI-native fintech Henon plants its flag in London, its push for 'zero-error' finance signals a new competitive era for private capital in EMEA.

A new software-defined radio isn't just a product launch; it's a strategic masterstroke, embracing open standards to reshape electronic warfare and investment.

A California fragrance brand conquered Korea and now targets the U.S. We dissect the data-driven strategy and AI's quiet role in its rapid rise.

A landmark deal between Airspan and Rakuten, backed by US funds, marks a new era for open networks, challenging the global telecom supply chain.

Exodus is using its Bitcoin treasury to buy a payments firm, but declining user metrics and a change in disclosure raise questions about this bold strategy.

With its new CRO from Asana and LinkedIn, HR tech unicorn Lattice is betting on a human-centric AI strategy to dominate the future of performance management.

PathAI's AIM-MASH tool just got dual FDA/EMA approval, a first for AI pathology. This could slash MASH drug development time and reshape clinical trials.

A logistics firm's stock soared 1,100% then collapsed overnight. Inside the alleged pump-and-dump scheme that reveals deep cracks in market integrity.

Ekinops unveils its C700HC chassis, a hybrid system designed to unify telecom offices and data centers, tackling the massive bandwidth demands of AI.

Rivals like OpenAI, Google, and Microsoft are joining forces under the Linux Foundation to build open standards for autonomous AI. What does this mean?

iDEAL's grip on Dutch iGaming isn't just about payments. Explore how trust, regulation, and tech created a unique digital fortress for online casinos.

A landmark deal between retail, ad-tech, and media giants aims to build Europe's most advanced data-driven advertising network. What does it mean for brands?

Cleric's new AI SRE agent promises to end engineering firefighting by learning from incidents. With $9.8M in funding, is this the future of system reliability?

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.

Black Friday’s record-breaking data demands reveal a blueprint for healthcare's own looming data crisis. What can medicine learn from retail's tech engine?

A new memory module may seem obscure, but it’s a key piece of the puzzle for building trusted AI, resilient 5G, and reliable edge computing.

A new partnership between evermore and Vallarta Supermarkets isn't just about groceries; it's about using tech to deliver health equity with cultural dignity.

A $2.4B tech acquisition seems distant from healthcare, but Qualcomm's move to buy Alphawave is building the essential AI infrastructure for medicine's future.